- Home
- TECH vs CELH Comparison
TECH vs CELH Comparison
Compare TECH & CELH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECH
- CELH
- Stock Information
- Founded
- TECH 1976
- CELH 2004
- Country
- TECH United States
- CELH United States
- Employees
- TECH N/A
- CELH N/A
- Industry
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- CELH Beverages (Production/Distribution)
- Sector
- TECH Health Care
- CELH Consumer Staples
- Exchange
- TECH Nasdaq
- CELH Nasdaq
- Market Cap
- TECH 8.2B
- CELH 15.7B
- IPO Year
- TECH 1989
- CELH N/A
- Fundamental
- Price
- TECH $59.64
- CELH $62.54
- Analyst Decision
- TECH Buy
- CELH Strong Buy
- Analyst Count
- TECH 13
- CELH 18
- Target Price
- TECH $70.58
- CELH $62.61
- AVG Volume (30 Days)
- TECH 2.7M
- CELH 5.4M
- Earning Date
- TECH 10-29-2025
- CELH 11-05-2025
- Dividend Yield
- TECH 0.54%
- CELH N/A
- EPS Growth
- TECH N/A
- CELH N/A
- EPS
- TECH 0.46
- CELH 0.39
- Revenue
- TECH $1,219,635,000.00
- CELH $1,666,480,000.00
- Revenue This Year
- TECH $3.97
- CELH $84.05
- Revenue Next Year
- TECH $7.81
- CELH $29.58
- P/E Ratio
- TECH $128.85
- CELH $156.73
- Revenue Growth
- TECH 5.23
- CELH 11.85
- 52 Week Low
- TECH $46.01
- CELH $21.10
- 52 Week High
- TECH $80.80
- CELH $64.81
- Technical
- Relative Strength Index (RSI)
- TECH 58.09
- CELH 63.81
- Support Level
- TECH $58.15
- CELH $59.73
- Resistance Level
- TECH $63.23
- CELH $64.81
- Average True Range (ATR)
- TECH 2.45
- CELH 2.28
- MACD
- TECH 0.13
- CELH 0.41
- Stochastic Oscillator
- TECH 68.31
- CELH 82.28
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
About CELH Celsius Holdings Inc.
Celsius Holdings plays in the energy drink subsegment of the global nonalcoholic beverage market, with 95% of revenue concentrated in North America. The firm now owns three energy drink brands: Celsius, Alani Nu, and Rockstar Energy. It dedicates its efforts to product innovation and marketing while outsourcing manufacturing and packaging to third-party co-packers and distribution to PepsiCo. The firm issued convertible preferred shares following PepsiCo's investments in 2022 and 2025, giving the latter an 11% stake in Celsius.